RIMADYL 20MG TABLETS FOR DOGS

Country: Ástralía

Tungumál: enska

Heimild: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Virkt innihaldsefni:

CARPROFEN

Fáanlegur frá:

ZOETIS AUSTRALIA PTY LTD

INN (Alþjóðlegt nafn):

carprofen(20mg/Tb)

Lyfjaform:

ORAL TABLET

Samsetning:

CARPROFEN ANTI-INFLAMMATORY-NONSTEROIDAL Active 20.0 mg/Tb

Einingar í pakka:

100 Tabs

Tegund:

VM - Veterinary Medicine

Framleitt af:

ZOETIS AUSTRALIA

Meðferðarhópur:

DOG | BITCH | CASTRATE | PUPPY

Lækningarsvæði:

MUSCULOSKELETAL SYSTEM

Ábendingar:

ANALGESIC | INFLAMMATORY JOINT DISEASE | ANTIPYRETIC | COLIC | MUSCLE RELAXANT | NON-INFECTIOUS JOINT DISEASE | SEDATIVE | SPASMOLYTIC

Vörulýsing:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ANALGESIC, INFLAMMATORY JOINT DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANALGESIC, INFLAMMATORY JOINT DISEASE]; A non-steroidal anti-inflammatory drug for the relief of pain and inflammation in dogs.Do not use in animals suffering from cardiac, hepatic or renal disease, or where there is evidence of blood dyscrasia or hypersensitivity to product. Avoid use in dehydrated, hypovolaemic or hypotensive animals, due to risk of increased renal toxicity.

Leyfisstaða:

Stopped

Leyfisdagur:

2022-07-01

Upplýsingar fylgiseðill

READ THE ENCLOSED LEAFLET BEFORE USING THIS
PRODUCT.
DIRECTIONS FOR USE
DOSAGE: 2-4 mg/kg bodyweight per day. Dose,
frequency and duration of treatment will be
dependent upon clinical response. See leaflet for full
details.
STORAGE: Store below 30°C (Room Temperature) in a
dry place out of direct sunlight.
PM63922
Pfizer Animal Health
A division of Pfizer Australia Pty Ltd
Wharf Rd, West Ryde. 2114
®Pfizer trademark ©2008
APVMA No.: 51747100/0508
Made in U.K.
Lot
Exp.
CODE NR
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
_EACH TABLET CONTAINS_
_20 MG CARPROFEN_
_A non-steroidal anti-inflammatory _
_drug for the relief of pain and _
_inflammation in dogs._
_100 TABLETS _
®
106 mm
32 mm
File Name: 51747_44709_100 tabs_Primary_MPL_V01.pdf
Dimension: 32mm x 106mm
Date: V01, 0508
Scale: 100% A4
APPROVED
LABEL
Info
PEST


Verified
FRONT
BACK
65 mm
405 mm
Rimadyl tablets are white and scored down the middle,
containing either 20 mg or 50 mg carprofen.
DESCRIPTION:
Rimadyl contains carprofen, a non-steroidal anti-inflammatory
drug (NSAID) of the propionic acid class. The chemical
name for carprofen, a substituted carbazole, is (±)-6-chloro-
α-methylcarbazole-2-acetic acid. The structural formula is:
Carprofen
is
a
white,
crystalline
compound
with
an
empirical formula of C
15
H
12
ClNO
2
and a molecular weight of
273.72.
It
is
freely
soluble
in
ethanol,
but
practically
insoluble in water at 25°C.
CLINICAL PHARMACOLOGY:
Carprofen is a non-narcotic, non-steroidal, anti-inflammatory
drug with characteristic analgesic and antipyretic activity,
approximately
equipotent
to
indomethacin
in
animal
models.
1
As
with
other
NSAIDs,
the
exact
mode
of
action
of
carprofen has not been established; however, inhibition of
prostaglandin synthesis accounts for at least part of its
mechanism of action.
2
Carprofen is a moderately potent inhibitor of phospholipase
A
2
and a reversible inhibitor of cyclooxygenase.
3
Two
unique
cyclooxygenases
have
been
described
in
mammals.
4
The
constitutive
cycloo

Vara einkenni

PRODUCT NAME: RIMADYL
TABLETS 20/50MG
PAGE: 1 OF 4
THIS REVISION ISSUED: APRIL, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Non-steroidal anti-inflammatory compound.
TRADE NAME:
RIMADYL
® TABLETS 20/50MG
PFIZER MSDS CODE:
MSDS055
PRODUCT USE:
Pain relief for musculoskeletal disorders and post-surgical treatment
for large
animals.
CREATION DATE:
MARCH, 2005
THIS VERSION ISSUED:
APRIL, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Hazardous according to the criteria of SWA Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R22. Harmful if swallowed.
SAFETY PHRASES:
S20, S45. When using, do not eat or drink. In case of accident or if
you feel unwell, contact a
doctor or Poisons Information Centre immediately (show the label where
possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Off-white tablets.
ODOUR:
Characteristic odour.
MAJOR HEALTH HAZARDS:
harmful if swallowed.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that this
product is not harmful. In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicat